Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
World Neurosurgery|July 10, 2021
The Medical Legal Environment in Neurosurgery: An Informative Overview of the Stages of Litigation and Distinct ChallengesDevon Lefever, Darian R Esfahani, Sandeep Kandregula, et al.
Lancet (London, England)|March 24, 2012
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trialsPeter M Rothwell, Jacqueline F Price, F Gerald R Fowkes, et al.
Blood|March 18, 2011
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoformTania L Slatter, Noelyn Hung, Hamish Campbell, et al.
British Journal of Cancer|July 20, 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trialMichael Friedlander, Linda Mileshkin, Janine Lombard, et al.
The American Journal of the Medical Sciences|July 30, 2023
Clinical trial participation among underserved communities: Insights from the Louisiana Community Engagement AllianceLeslie S Craig, Daniel F Sarpong, Erin M Peacock, et al.
Rheumatology (Oxford, England)|September 10, 2020
Occupational silica exposure in an Australian systemic sclerosis cohortShreeya Patel, Kathleen Morrisroe, Susanna Proudman, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Arthritis Research & Therapy|May 12, 2023
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosisJessica L Fairley, Dylan Hansen, Laura Ross, et al.
Annals of Internal Medicine|July 31, 2023
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk StratificationLaurence Duquenne, Elizabeth M Hensor, Michelle Wilson, et al.
Kidney International|June 7, 2013
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantationMatthew P Welberry Smith, Alexandre Zougman, David A Cairns, et al.
Pageof 11